NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

View Paper

In the News

Twinstrand Biosciences Logo
CISION PR Newswire - February 26, 2026

Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences

Read More
BusinessWire - August 24, 2026

TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University of Washington More Than $245.2 Million in Damages, Accrued Royalties and Interest

READ MORE
CISION PR Newswire - April 24, 2024

TwinStrand Biosciences Initiates Regulatory Approval Process for Duplex Sequencing Mutagenesis Assays with OECD

Read More
SEATTLE PR Newswire - July 31, 2024

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology

Read More
CISION PR Newswire - November 15, 2023

Federal Jury Finds Guardant Health Willfully Infringes University of Washington Duplex Sequencing Patents Exclusively Licensed to TwinStrand Biosciences, Inc., Awards $83.4M in Damages; PTAB Rejects Invalidity Arguments on UW Patents

Read More
CISION PR Newswire - August 29, 2023

TwinStrand Biosciences Announces Executive Leadership Changes to Accelerate Adoption of Duplex Sequencing for Minimal Residual Disease (MRD) Testing for Hematological Malignancies and Cell Therapy Monitoring

Read More
Business Wire - October 13, 2022

TwinStrand Biosciences Announces Leadership Transition

Read More
Globe Newswire - June 06, 2022

Singular Genomics and TwinStrand Biosciences Collaborate to Develop Ultra-high Accuracy NGS Solutions for the G4 Platform

Read More
Business Wire - June 06, 2022

TwinStrand Biosciences to Showcase Recent Applications of its Duplex Sequencing Technology at the 2022 AGBT Annual Meeting

Read More
Life Science Washington - April 20, 2022

Life Science Innovation Northwest 2022

Our CEO, Jesse Salk MD, PhD will be speaking at the Life Sciences Innovation Northwest (LSINW) 2022 Convention during the Research Tools & Medical Device session.

Wednesday, April 20th, 2022 – 2:46pm PST

Read More
Inside Precision News - April 12, 2022

How Duplex Sequencing Can Improve MRD Detection: An Interview with Jesse Salk, MD, PhD, CEO of TwinStrand Biosciences

Read the Interview

For Research Use Only. Not for use in diagnostic procedures.

©2026 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices